The impact of differences between patient and general population EQ-5D-3l values on the mean tariff scores of different patient groups

Value in Health

Volumn 17, Issue 4, 2014, Pages 364-371

  Little, Matthew H R ^a,b   Reitmeir, Peter ^b   Peters, Annette ^b   Leidl, Reiner ^b,c  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b Joint Mass Spectrometry Centre Cooperation Group Comprehensive Molecular Analytics   (United Kingdom)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

EQ 5D; experience; quality of life; visual analogue scale

Indexed keywords

ANXIETY; ARTICLE; CEREBROVASCULAR ACCIDENT; COMORBIDITY; DEPRESSION; DIABETES MELLITUS; ECONOMIC EVALUATION; EQ 5D 3L TARIFF SCORE; EXPERIENCED HEALTH STATE TARIFF; GIVEN HEALTH STATE TARIFF; HEALTH STATUS; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; NEOPLASM; POPULATION; PRIORITY JOURNAL; QUESTIONNAIRE; RESOURCE ALLOCATION; SCORING SYSTEM; SELF CARE; VISUAL ANALOG SCALE;

EQ-5D; EXPERIENCE; QUALITY OF LIFE; VISUAL ANALOGUE SCALE;

DATA COLLECTION; DECISION MAKING; EUROPE; HEALTH STATUS INDICATORS; HUMANS; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 84903311266     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1016/j.jval.2014.02.002     Document Type: Article

References (31)

1. EuroQol Group EuroQol - a new facility for the measurement of health-related quality of life Health Policy 16 1990 199 208
2. M. Drummond, M. Sculpher, and G. Torrance et al. Methods for the Economic Evaluation of Health Care Programmes 2005 Oxford University Press Oxford
3. National Institute for Health and Care Excellence Guide to the Methods of Technology Appraisal 2013 National Institute for Health and Care Excellence London
4. Department of Health. Equity and Excellence: Liberating the NHS [white paper] 2010 Stationary Office London, UK
5. EuroQol Group. EuroQol Group reference search. Available from: http://www.euroqol.org/EQ-5D-3L-references/reference-search.html. [Accessed July 12, 2013].
6. German Social Code (Sozialgesetzbuch) Book V (SGB V), Section 35, Paragraph 1b.
7. M.C. Weinstein, G. Torrance, and A. McGuire QALYs: the basics Value Health 12 Suppl. 1 2009 S5 S9
8. P. Dolan, and D. Kahneman Interpretations of utility and their implications for the valuation of health Econ J 118 2008 215 234
9. J. Brazier, R. Akehurst, and A. Brennan et al. Should patients have a greater role in valuing health states? Appl Health Econ Health Policy 4 2005 201 208
10. M.R. Gold, J.E. Siegel, L.B. Russel, and M.C. Weinstein Cost-Effectiveness in Health and Medicine 1996 Oxford University Press Oxford
11. 2006 Canadian Agency for Drugs and Technologies in Health Ottawa, Canada
12. K. Burström, S. Sun, and U.-G. Gerdtham et al. Swedish experience-based value sets for EQ-5D health states Qual Life Res 23 2014 431 442
13. Y. Peeters, and A.M. Stiggelbout Health state valuations of patients and the general public analytically compared: a meta-analytical comparison of patient and population health state utilities Value Health 13 2010 306 309
14. R.P. Insinga, and D.G. Fryback Understanding differences between self-ratings and population ratings for health in the EuroQOL Qual Life Res 12 2003 611 619
15. G.A. De Wit, J.J.V. Busschbach, and F.T. De Charro Sensitivity and perspective in the valuation of health status: whose values count? Health Econ 9 2000 109 126
16. P.A. Ubel, G. Loewenstein, and C. Jepson Whose quality of life? A commentary exploring discrepancies between health state evaluations of patients and the general public Qual Life Res 12 2003 599 607
17. P. Kind, and P. Dolan The effect of past and present illness experience on the valuations of health States Med Care 33 1995 AS255 AS263
18. R. Leidl, and P. Reitmeir A value set for the EQ-5D based on experienced health states: development and testing for the German population Pharmacoeonomics 29 2011 521 534
19. R. Mann, J. Brazier, and A. Tsuchiya A comparison of patient and general population weightings of EQ-5D dimensions Health Econ 18 2009 363 372
20. K. Rand-Hendriksen, L. Augestad, and I. Kristiansen et al. Comparison of hypothetical and experienced EQ-5D valuations: relative weights of the five dimensions Qual Life Res 21 2012 1005 1012
21. W. Greiner, T. Weijnen, and M. Nieuwenhuizen et al. A single European currency for EQ-5D health states Eur J Health Econ 4 2003 222 231
22. J. Brazier, M. Deverill, and C. Green et al. A review of the use of health status measures in economic evaluation Health Technol Assess 3 1999 1 164
23. J. Broome QALYs J Pub Econ 50 1993 149 167
24. D. Parkin, and N. Devlin Is there a case for using visual analogue scale valuations in cost-utility analysis? Health Econ 15 2006 653 664
25. P. Dolan Modeling valuations for EuroQol health states Med Care 35 1997 1095 1108
26. S. Bernert, A. Fernández, and J.M. Haro et al. Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries Value Health 12 2009 750 758
27. M. Hunger, C. Sabariego, and B. Stollenwerk et al. Validity, reliability and responsiveness of the EQ-5D in German stroke patients undergoing rehabilitation Qual Life Res 21 2012 1205 1216
28. R. Leidl, P. Reitmeir, and H.-H. König et al. The performance of a value set for the EQ-5D based on experienced health states in patients with inflammatory bowel disease Value Health 15 2012 151 157
29. R. Holle, M. Happich, and H. Löwel et al. KORA - a research platform for population based health research Das Gesundheitswesen 67 2005 19 25
30. A. Williams The Measurement and Valuation of Health: A Chronicle. Discussion paper #136 1995 Centre for Health Economics, The University of York York, England
31. L.A. Augestad, K. Rand-Hendriksen, K. Stavem, and I.S. Kristiansen Time trade-off and attitudes toward euthanasia: implications of using 'death' as an anchor in health state valuation Qual Life Res 22 2013 705 714